BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34025421)

  • 1. Combination of Wogonin and Artesunate Exhibits Synergistic anti-Hepatocellular Carcinoma Effect by Increasing DNA-Damage-Inducible Alpha, Tumor Necrosis Factor α and Tumor Necrosis Factor Receptor-Associated Factor 3-mediated Apoptosis.
    Chen M; Wu HL; Wong TS; Chen B; Gong RH; Wong HLX; Xiao H; Bian Z; Kwan HY
    Front Pharmacol; 2021; 12():657080. PubMed ID: 34025421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor and tumor necrosis factor α cooperatively promote the motility of hepatocellular carcinoma cell lines via synergistic induction of fibronectin by NF-κB/p65.
    Liu ZC; Ning F; Wang HF; Chen DY; Cai YN; Sheng HY; Lash GE; Liu L; Du J
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2568-2582. PubMed ID: 28844984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
    Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
    Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
    Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model.
    Kwak MS; Yu SJ; Yoon JH; Lee SH; Lee SM; Lee JH; Kim YJ; Lee HS; Kim CY
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):2037-45. PubMed ID: 25989942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFα induces Ca
    Zhu J; Jin M; Wang J; Zhang H; Wu Y; Li D; Ji X; Yang H; Yin C; Ren T; Xing J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):43. PubMed ID: 29506556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma repression by TNFα-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization.
    Li D; Fu J; Du M; Zhang H; Li L; Cen J; Li W; Chen X; Lin Y; Conway EM; Pikarsky E; Wang H; Pan G; Ji Y; Wang HY; Hui L
    Hepatology; 2016 Oct; 64(4):1105-20. PubMed ID: 27177758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor necrosis factor-α antibodies as a noveltherapy for hepatocellular carcinoma.
    Li W; Jian YB
    Exp Ther Med; 2018 Aug; 16(2):529-536. PubMed ID: 30116311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant soluble CD40 ligand enhances Wogonin-induced antitumor activity].
    Zhou YQ; Li DX; Zheng XL; Yan YY; Lin Y; Wang X; Liao LC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):859-64. PubMed ID: 24490490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and Therapeutic Values of Tumor Necrosis Factor-Alpha in Hepatocellular Carcinoma.
    Wang H; Liu J; Hu X; Liu S; He B
    Med Sci Monit; 2016 Oct; 22():3694-3704. PubMed ID: 27739418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivate isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/M cell cycle arrest and apoptosis.
    Chen L; Tian H; Li M; Ge C; Zhao F; Zhang L; Li H; Liu J; Wang T; Yao M; Li J
    Tumour Biol; 2016 May; 37(5):5951-61. PubMed ID: 26596832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition.
    Rong LW; Wang RX; Zheng XL; Feng XQ; Zhang L; Zhang L; Lin Y; Li ZP; Wang X
    Oncol Lett; 2017 Jun; 13(6):5028-5034. PubMed ID: 28599504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1.
    Chen YC; Shen SC; Lee WR; Lin HY; Ko CH; Shih CM; Yang LL
    Arch Toxicol; 2002 Jun; 76(5-6):351-9. PubMed ID: 12107653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation.
    Hong M; Li J; Li S; M Almutairi M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31752383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
    Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
    Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
    Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
    Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway.
    Li W; Ma G; Deng Y; Wu Q; Wang Z; Zhou Q
    Gene; 2021 Jan; 766():145134. PubMed ID: 32898605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different apoptotic regulation of TRAIL-caspase pathway in HBV- and HCV-related hepatocellular carcinoma.
    Yano Y; Hayashi Y; Nakaji M; Nagano H; Seo Y; Ninomiya T; Yoon S; Wada A; Hirai M; Kim SR; Yokozaki H; Kasuga M
    Int J Mol Med; 2003 Apr; 11(4):499-504. PubMed ID: 12632104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma.
    Zuo C; Qiu X; Liu N; Yang D; Xia M; Liu J; Wang X; Zhu H; Xie H; Dan H; Li Q; Wu Q; Burns M; Liu C
    Exp Cell Res; 2015 May; 333(2):316-326. PubMed ID: 25724899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.